scholarly journals Successful Treatment of Antibody-Mediated Rejection by De Novo Donor Specific Antibody After Primary Renal Transplantation in a Recipient From a Cadaveric Donor: A Case Report

2020 ◽  
Vol 52 (6) ◽  
pp. 1928-1930
Author(s):  
Tomohisa Matsunaga ◽  
Hajime Hirano ◽  
Ryoichi Maenosono ◽  
Takeshi Tsutsumi ◽  
Takuya Tsujino ◽  
...  
2014 ◽  
Vol 75 (5) ◽  
pp. 462-465 ◽  
Author(s):  
Pietro E. Cippà ◽  
Ariana Gaspert ◽  
Christoph Etter ◽  
Zehra Guenduez ◽  
Sylvie Ferrari-Lacraz ◽  
...  

Nephron ◽  
2020 ◽  
pp. 1-5
Author(s):  
Takahiro Tsuji ◽  
Sari Iwasaki ◽  
Keishi Makita ◽  
Teppei Imamoto ◽  
Naomichi Ishidate ◽  
...  

<b><i>Aim:</i></b> Chronic active antibody-mediated rejection (CAABMR) is an important cause of late-stage renal allograft loss. Early inflammatory events such as acute rejection and infection after transplantation are considered to be the risk factors of de novo donor-specific antibody (dnDSA) production. In this study, we investigated the relationship between pre­disposing T-cell-mediated rejection and dnDSA-positive CAABMR. <b><i>Methods:</i></b> We recruited 365 patients who underwent ABO-compatible renal transplantation at our hospital. Among them, 16 patients diagnosed as having dnDSA-positive CAABMR were designated as a CAABMR group, and 38 randomly selected patients were designated as a control group. All biopsies from 1 month after transplantation were included in the study. The presence or absence of borderline changes (BLCs), acute T-cell-mediated rejection (ATMR), microvascular inflammation (MVI), and C4d positive on peritubular capillaries (C4d-P) was examined. <b><i>Results:</i></b> In the CAABMR group, BLC/ATMR was found in 12 cases (75%), and the mean duration until appearance of BLC/ATMR was 282.7 ± 328.7 days. C4d-P was found in 11 cases (68.8%), and the mean duration until its appearance was 1,432 ± 1,307 days. MVI was found in all cases, and the mean duration until its appearance was 1,333 ± 1,126 days. The mean duration until diagnosis of CAABMR was 2,268 ± 1,191 days. In the control group, BLC/ATMR was found in 13 cases (34.2%), and the mean duration until the appearance of BLC/ATMR was 173.1 ± 170.4 days. C4d-P was found in 2 cases (5.3%), and the durations until its appearance were 748 and 1,881 days. No cases of MVI were found in the control group. The frequency of BLC/ATMR was significantly higher in the CAABMR group (<i>p</i> &#x3c; 0.01). <b><i>Conclusion:</i></b> Preceding BLC/ATMR is associated with the development of CAABMR with dnDSA.


2016 ◽  
Vol 77 (11) ◽  
pp. 1076-1083 ◽  
Author(s):  
Stéphanie Malard-Castagnet ◽  
Emilie Dugast ◽  
Nicolas Degauque ◽  
Annaïck Pallier ◽  
Jean Paul Soulillou ◽  
...  

2013 ◽  
Vol 45 (3) ◽  
pp. 1213-1215 ◽  
Author(s):  
S. Westphal ◽  
S. Hansson ◽  
G. Stelin ◽  
J. Holgersson ◽  
L. Mjörnstedt ◽  
...  

2022 ◽  
Vol 12 (1) ◽  
pp. 15-20
Author(s):  
Prakash I Darji ◽  
Himanshu A Patel ◽  
Bhavya P Darji ◽  
Ajay Sharma ◽  
Ahmed Halawa

Sign in / Sign up

Export Citation Format

Share Document